AlphAIalphai — Financial news for AI agents
StockNASDAQ · US · USDHealthcare · Biotechnology

$HURA

TuHURA Biosciences, Inc./NV

Insider trades
Price · $HURAvia TradingView
AI sentiment · 7d1 articles
AUG 7net (bullish − bearish)AUG 13
Bullish
0
Neutral
1
Bearish
0
Insider · 30dAll trades →

No SEC Form 4 filings for $HURA in the last 30 days.

See all $HURA insider activity →
Top stories · $HURAMore →
AUG 13·SEC EDGAR 8-KMed

TuHURA Biosciences, Inc./NV (HURA): Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

TuHURA Biosciences, Inc./NV (HURA) filed an SEC Form 8-K — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. 8-K 0001498382 false TuHURA Biosciences, Inc./NV 0001498382 2026-08-07 2026-08-07 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earlies

JUL 29·SEC EDGAR 8-K

TuHURA Biosciences, Inc./NV (HURA): Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

TuHURA Biosciences, Inc./NV (HURA) filed an SEC Form 8-K — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. 8-K false 0001498382 TuHURA Biosciences, Inc./NV 0001498382 2026-07-28 2026-07-28 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earlies

JUL 7·SEC EDGAR 8-K

TuHURA Biosciences, Inc./NV (HURA): Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

TuHURA Biosciences, Inc./NV (HURA) filed an SEC Form 8-K — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. 8-K 0001498382 false TuHURA Biosciences, Inc./NV 0001498382 2026-06-30 2026-06-30 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earlies

HURA sentiment & insider activity

Over the past 7 days, alphai's AI scored 1 news story mentioning HURA (TuHURA Biosciences, Inc./NV). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.

Recent HURA coverage spans corporate actions and financial news.

What's driving HURA

  • The filing signals incremental liquidity access under an existing revolver, which can modestly reduce near-term funding risk but also highlights ongoing capital needs.

    SEC EDGAR 8-K · Aug 13, 2026

  • The incremental revolver draw increases near-term liquidity but also highlights ongoing financing needs and potential covenant/compliance risk.

    SEC EDGAR 8-K · Jul 29, 2026

  • The 8-K discloses a fresh debt draw, increasing near-term liquidity but also adding leverage/interest-rate and covenant risk.

    SEC EDGAR 8-K · Jul 7, 2026

  • TuHURA Biosciences reported a 75% increase in revenue in Q2 2025, driven by progress in immuno-oncology therapies and initiation of a pivotal Phase 3 trial for IFx-2.0. The positive financial results and clinical developments suggest potential upside, but valuation may be stretched.

    Motley Fool · Aug 15, 2025

  • No significant activity or news related to HURA Biosciences (NASDAQ:HURA). The sentiment score is neutral, and the relevance to current market movements is low.

    Benzinga · Aug 12, 2025

alphai scores every news story that mentions HURA with an AI model for sentiment and relevance, and aggregates insider trades from TuHURA Biosciences, Inc./NV's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $HURA

Score
AUG 13$HURAMedSEC EDGAR 8-K

TuHURA Biosciences, Inc./NV (HURA): Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

TuHURA Biosciences, Inc./NV (HURA) filed an SEC Form 8-K — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. 8-K 0001498382 false TuHURA Biosciences, Inc./NV 0001498382 2026-08-07 2026-08-07 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earlies

2 min read
JUL 29$HURAMedSEC EDGAR 8-K

TuHURA Biosciences, Inc./NV (HURA): Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

TuHURA Biosciences, Inc./NV (HURA) filed an SEC Form 8-K — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. 8-K false 0001498382 TuHURA Biosciences, Inc./NV 0001498382 2026-07-28 2026-07-28 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earlies

3 min read
JUL 7$HURAMedSEC EDGAR 8-K

TuHURA Biosciences, Inc./NV (HURA): Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

TuHURA Biosciences, Inc./NV (HURA) filed an SEC Form 8-K — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. 8-K 0001498382 false TuHURA Biosciences, Inc./NV 0001498382 2026-06-30 2026-06-30 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earlies

2 min read
AUG 15$HURAMedMotley Fool

TuHURA R&D Jumps 75% in Q2

TuHURA Biosciences ( NASDAQ:HURA ) , a biotechnology company focused on immuno-oncology therapies, released its second quarter results on August 14, 2025. The big headlines included the start of a pivotal Phase 3 clinical trial for IFx-2.0, a new product candidate, under a unique regulatory ...

4 min read

Related tickers

More in Biotechnology